BCL
BHC icon

Bracebridge Capital LLC’s Bausch Health BHC Stock Holding History

Bracebridge Capital LLC’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-118,795
Closed -$818K – 87
2022
Q3 		$818K Buy
+118,795
New +$825K 0.14% 76

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Bracebridge Capital LLC's BHC Position: Q4 2022 in Review

Bracebridge Capital LLC sold out of Bausch Health (BHC) in Q4 2022, closing a stake of 118,795 shares — an estimated $818K sold.

Bracebridge Capital LLC first reported a position in BHC in Q3 2022 and held it in 1 quarter. The position peaked at $818K in Q3 2022. 262 funds tracked by Wall St. Rank hold BHC as of Q4 2022.

  • Bracebridge Capital LLC reported no remaining Bausch Health position as of Q4 2022 after selling out during the quarter.
  • Bracebridge Capital LLC sold 118,795 Bausch Health shares in Q4 2022, an estimated $818K.
  • Bracebridge Capital LLC first reported a position in Bausch Health in Q3 2022 and held it in 1 quarter.
  • Bracebridge Capital LLC's Bausch Health position peaked at $818K in Q3 2022.
  • 262 funds tracked by Wall St. Rank held Bausch Health as of Q4 2022.

Based on Bracebridge Capital LLC's 13F filing for Q4 2022, filed 10 Feb 2023.